Pros and Cons for Fluorescent
Cytogenetics
Fluorescent in situ hybridization (FISH)
Multiple myeloma
Next generation sequencing (NGS)
Journal
Balkan journal of medical genetics : BJMG
ISSN: 1311-0160
Titre abrégé: Balkan J Med Genet
Pays: Poland
ID NLM: 9806959
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
entrez:
5
4
2021
pubmed:
6
4
2021
medline:
6
4
2021
Statut:
epublish
Résumé
Multiple myeloma (MM) is one of the plasma cell-related hematological malignancies exceeding 10.0% of all marrow cells, and they make a paraprotein that is a marker of the disease. Myeloma is one of the most common types of hematological malignancies in humans. Genetic bio-markers have been used for prognostic markers in patients diagnosed with MM. The genetic and genomic changes have been identified using karyotyping, fluorescent
Identifiants
pubmed: 33816073
doi: 10.2478/bjmg-2020-0020
pii: bjmg-2020-0020
pmc: PMC8009570
doi:
Types de publication
Journal Article
Langues
eng
Pagination
59-64Informations de copyright
© 2020 Ikbal Atli E, Gurkan H, Onur Kirkizlar H, Atli E, Demir S, Yalcintepe S, Kalkan R, Demir AM, published by Sciendo.
Références
Blood Cancer J. 2019 Dec 11;9(12):101
pubmed: 31827071
Am J Hematol. 2014 Oct;89(10):999-1009
pubmed: 25223428
Br Med Bull. 2015 Mar;113(1):15-30
pubmed: 25662536
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Blood. 2011 May 5;117(18):4696-700
pubmed: 21292777
Leukemia. 2018 Dec;32(12):2604-2616
pubmed: 29789651
Cancer Res. 2004 Feb 15;64(4):1546-58
pubmed: 14989251
Mayo Clin Proc. 2010 Jun;85(6):532-7
pubmed: 20511484
Front Oncol. 2019 Aug 20;9:699
pubmed: 31482061
Ann Oncol. 2003 Nov;14(11):1667-72
pubmed: 14581276
Turk J Haematol. 2012 Jun;29(2):135-42
pubmed: 24744644
Int J Lab Hematol. 2019 Feb;41(1):5-14
pubmed: 29971938
Blood Res. 2016 Jun;51(2):122-6
pubmed: 27382557
Indian J Hematol Blood Transfus. 2020 Apr;36(2):284-291
pubmed: 32425379